Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Systemic safety analysis of mycophenolate in Graves' orbitopathy.

Lee ACH, Riedl M, Frommer L, Diana T, Kahaly GJ.

J Endocrinol Invest. 2019 Dec 13. doi: 10.1007/s40618-019-01161-z. [Epub ahead of print]

PMID:
31834613
2.

The International/Canadian Hereditary Angioedema Guideline.

Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hébert J, Kanani A, Keith P, Lacuesta G, Waserman S, Yang B, Aygören-Pürsün E, Bernstein J, Bork K, Caballero T, Cicardi M, Craig T, Farkas H, Grumach A, Katelaris C, Longhurst H, Riedl M, Zuraw B, Berger M, Boursiquot JN, Boysen H, Castaldo A, Chapdelaine H, Connors L, Fu L, Goodyear D, Haynes A, Kamra P, Kim H, Lang-Robertson K, Leith E, McCusker C, Moote B, O'Keefe A, Othman I, Poon MC, Ritchie B, St-Pierre C, Stark D, Tsai E.

Allergy Asthma Clin Immunol. 2019 Nov 25;15:72. doi: 10.1186/s13223-019-0376-8. eCollection 2019. Review.

3.

Regulation of small heat-shock proteins by hetero-oligomer formation.

Mymrikov EV, Riedl M, Peters C, Weinkauf S, Haslbeck M, Buchner J.

J Biol Chem. 2020 Jan 3;295(1):158-169. doi: 10.1074/jbc.RA119.011143. Epub 2019 Nov 25.

PMID:
31767683
4.

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study.

Li HH, Zuraw B, Longhurst HJ, Cicardi M, Bork K, Baker J, Lumry W, Bernstein J, Manning M, Levy D, Riedl MA, Feuersenger H, Prusty S, Pragst I, Machnig T, Craig T; COMPACT Investigators.

Allergy Asthma Clin Immunol. 2019 Aug 28;15:49. doi: 10.1186/s13223-019-0362-1. eCollection 2019.

5.

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage.

Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M.

Diabetes Metab Syndr Obes. 2019 Jul 24;12:1225-1237. doi: 10.2147/DMSO.S214288. eCollection 2019. Erratum in: Diabetes Metab Syndr Obes. 2019 Aug 14;12:1397.

6.

Vaccination Status in Pediatric Solid-Organ Transplant Recipients and Their Household Members.

Cortina G, Ojinaga V, Zlamy M, Giner T, Riedl M, Rauchenzauner M, Entenmann A, Müller T.

Exp Clin Transplant. 2019 Aug;17(4):429-434. doi: 10.6002/ect.2018.0184. Epub 2019 May 2.

7.

[Other specific types of diabetes and exocrine pancreatic insufficiency (Update 2019)].

Kaser S, Winhofer-Stöckl Y, Kazemi-Shirazi L, Hofer SE, Brath H, Sourij H, Vila G, Abrahamian H, Riedl M, Weitgasser R, Resl M, Clodi M, Luger A.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):16-26. doi: 10.1007/s00508-019-1454-0. Review. German.

PMID:
30980164
8.

[Diabetes education and counselling in adult patients with diabetes (Update 2019)].

Weitgasser R, Clodi M, Cvach S, Riedl M, Lechleitner M, Ludvik B.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):110-114. doi: 10.1007/s00508-019-1449-x. Review. German.

PMID:
30980161
9.

[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].

Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Lechleitner M, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):27-38. doi: 10.1007/s00508-019-1471-z. Review. German.

10.

[Insulin therapy of type 2 diabetes mellitus (Update 2019)].

Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):39-46. doi: 10.1007/s00508-019-1492-7. Review. German.

PMID:
30980147
11.

Kidney disease and organ transplantation in methylmalonic acidaemia.

Noone D, Riedl M, Atkison P, Avitzur Y, Sharma AP, Filler G, Siriwardena K, Prasad C.

Pediatr Transplant. 2019 Jun;23(4):e13407. doi: 10.1111/petr.13407. Epub 2019 Apr 11.

PMID:
30973671
12.

AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection.

Gore R, Riedl MS, Kitto KF, Fairbanks CA, Vulchanova L.

Methods Mol Biol. 2019;1950:407-415. doi: 10.1007/978-1-4939-9139-6_24.

PMID:
30783988
13.

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.

Craig T, Zuraw B, Longhurst H, Cicardi M, Bork K, Grattan C, Katelaris C, Sussman G, Keith PK, Yang W, Hébert J, Hanzlikova J, Staubach-Renz P, Martinez-Saguer I, Magerl M, Aygören-Pürsün E, Farkas H, Reshef A, Kivity S, Neri S, Crisan I, Caballero T, Baeza ML, Hernandez MD, Li H, Lumry W, Bernstein JA, Hussain I, Anderson J, Schwartz LB, Jacobs J, Manning M, Levy D, Riedl M, Christiansen S, Feuersenger H, Pragst I, Mycroft S, Pawaskar D, Jacobs I; COMPACT Investigators.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1793-1802.e2. doi: 10.1016/j.jaip.2019.01.054. Epub 2019 Feb 15.

14.

Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study.

Lumry WR, Martinez-Saguer I, Yang WH, Bernstein JA, Jacobs J, Moldovan D, Riedl MA, Johnston DT, Li HH, Tang Y, Schranz J, Lu P, Vardi M, Farkas H; SAHARA study group.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1610-1618.e4. doi: 10.1016/j.jaip.2019.01.021. Epub 2019 Jan 23.

15.

Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings.

Craig T, Lumry W, Cicardi M, Zuraw B, Bernstein JA, Anderson J, Jacobs J, Riedl MA, Manning ME, Banerji A, Gower RG, Caballero T, Farkas H, Feuersenger H, Jacobs I, Machnig T, Longhurst H; COMPACT Investigators.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):2035-2038. doi: 10.1016/j.jaip.2019.01.007. Epub 2019 Jan 17. No abstract available.

16.

Increased growth rate and productivity following stable depletion of miR-7 in a mAb producing CHO cell line causes an increase in proteins associated with the Akt pathway and ribosome biogenesis.

Coleman O, Suda S, Meiller J, Henry M, Riedl M, Barron N, Clynes M, Meleady P.

J Proteomics. 2019 Mar 20;195:23-32. doi: 10.1016/j.jprot.2019.01.003. Epub 2019 Jan 11.

PMID:
30641232
17.

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies.

Busse PJ, Farkas H, Banerji A, Lumry WR, Longhurst HJ, Sexton DJ, Riedl MA.

BioDrugs. 2019 Feb;33(1):33-43. doi: 10.1007/s40259-018-0325-y. Review.

18.

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.

Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I, Davis-Lorton M, Zanichelli A, Li HH, Craig T, Jacobs J, Johnston DT, Shapiro R, Yang WH, Lumry WR, Manning ME, Schwartz LB, Shennak M, Soteres D, Zaragoza-Urdaz RH, Gierer S, Smith AM, Tachdjian R, Wedner HJ, Hebert J, Rehman SM, Staubach P, Schranz J, Baptista J, Nothaft W, Maurer M; HELP Investigators.

JAMA. 2018 Nov 27;320(20):2108-2121. doi: 10.1001/jama.2018.16773. Erratum in: JAMA. 2019 Apr 23;321(16):1636.

19.

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.

Riedl MA, Banerji A, Manning ME, Burrell E, Joshi N, Patel D, Machnig T, Tai MH, Watson DJ.

Orphanet J Rare Dis. 2018 Oct 12;13(1):180. doi: 10.1186/s13023-018-0922-3.

20.

Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency.

Craig T, Busse P, Gower RG, Johnston DT, Kashkin JM, Li HH, Lumry WR, Riedl MA, Soteres D.

Ann Allergy Asthma Immunol. 2018 Dec;121(6):673-679. doi: 10.1016/j.anai.2018.07.025. Epub 2018 Jul 27. Review.

PMID:
30056152
21.

Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema.

Pawaskar D, Tortorici MA, Zuraw B, Craig T, Cicardi M, Longhurst H, Li HH, Lumry WR, Martinez-Saguer I, Jacobs J, Bernstein JA, Riedl MA, Katelaris CH, Keith PK, Feussner A, Sidhu J.

Clin Exp Allergy. 2018 Oct;48(10):1325-1332. doi: 10.1111/cea.13220. Epub 2018 Aug 26.

22.

Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.

Lara-Marquez ML, Christiansen SC, Riedl MA, Herschbach J, Zuraw BL.

Clin Exp Allergy. 2018 Nov;48(11):1429-1438. doi: 10.1111/cea.13219. Epub 2018 Aug 21.

PMID:
29957871
23.

Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.

Baker JW, Bernstein JA, Harper JR, Relan A, Riedl MA.

Allergy Asthma Proc. 2018 Sep 28;39(5):359-364. doi: 10.2500/aap.2018.39.4151. Epub 2018 Jun 28.

PMID:
29954477
24.

Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.

Henry Li H, Riedl M, Kashkin J.

Clin Rev Allergy Immunol. 2019 Apr;56(2):207-218. doi: 10.1007/s12016-018-8684-1. Review.

PMID:
29909591
25.

Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity.

Skorput AGJ, Zhang X, Waataja JJ, Peterson CD, Riedl MS, Kitto KF, Truong H, Huffman C, Salton SR, Fairbanks CA, Honda CN, Vulchanova L.

Pain. 2018 Sep;159(9):1802-1813. doi: 10.1097/j.pain.0000000000001277.

26.

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.

Riedl MA, Aygören-Pürsün E, Baker J, Farkas H, Anderson J, Bernstein JA, Bouillet L, Busse P, Manning M, Magerl M, Gompels M, Huissoon AP, Longhurst H, Lumry W, Ritchie B, Shapiro R, Soteres D, Banerji A, Cancian M, Johnston DT, Craig TJ, Launay D, Li HH, Liebhaber M, Nickel T, Offenberger J, Rae W, Schrijvers R, Triggiani M, Wedner HJ, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan WP, Maurer M.

Allergy. 2018 Sep;73(9):1871-1880. doi: 10.1111/all.13466. Epub 2018 Jun 17.

27.

Hereditary angioedema from the patient's perspective: A follow-up patient survey.

Banerji A, Li Y, Busse P, Riedl MA, Holtzman NS, Li HH, Davis-Lorton M, Bernstein JA, Frank M, Castaldo AJ, Long J, Zuraw B, Lumry W, Christiansen S.

Allergy Asthma Proc. 2018 May 1;39(3):212-223. doi: 10.2500/aap.2018.39.4123.

28.

C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.

Riedl MA, Relan A, Harper JR, Cicardi M.

Lancet. 2018 Apr 7;391(10128):1356. doi: 10.1016/S0140-6736(18)30573-7. No abstract available.

PMID:
29636270
29.

Relative antibacterial functions of complement and NETs: NETs trap and complement effectively kills bacteria.

Azzouz L, Cherry A, Riedl M, Khan M, Pluthero FG, Kahr WHA, Palaniyar N, Licht C.

Mol Immunol. 2018 May;97:71-81. doi: 10.1016/j.molimm.2018.02.019. Epub 2018 Mar 20.

PMID:
29571059
30.

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.

Kahaly GJ, Riedl M, König J, Pitz S, Ponto K, Diana T, Kampmann E, Kolbe E, Eckstein A, Moeller LC, Führer D, Salvi M, Curro N, Campi I, Covelli D, Leo M, Marinò M, Menconi F, Marcocci C, Bartalena L, Perros P, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO).

Lancet Diabetes Endocrinol. 2018 Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2. Epub 2018 Jan 31.

PMID:
29396246
31.

Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.

Lumry WR, Craig T, Zuraw B, Longhurst H, Baker J, Li HH, Bernstein JA, Anderson J, Riedl MA, Manning ME, Keith PK, Levy DS, Caballero T, Banerji A, Gower RG, Farkas H, Lawo JP, Pragst I, Machnig T, Watson DJ.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1733-1741.e3. doi: 10.1016/j.jaip.2017.12.039. Epub 2018 Jan 31.

32.

Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement.

Freeman SA, Vega A, Riedl M, Collins RF, Ostrowski PP, Woods EC, Bertozzi CR, Tammi MI, Lidke DS, Johnson P, Mayor S, Jaqaman K, Grinstein S.

Cell. 2018 Jan 11;172(1-2):305-317.e10. doi: 10.1016/j.cell.2017.12.023.

33.

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update.

Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K, Bowen T, Balle Boysen H, Farkas H, Grumach AS, Hide M, Katelaris C, Lockey R, Longhurst H, Lumry WR, Martinez-Saguer I, Moldovan D, Nast A, Pawankar R, Potter P, Riedl M, Ritchie B, Rosenwasser L, Sánchez-Borges M, Zhi Y, Zuraw B, Craig T.

Allergy. 2018 Aug;73(8):1575-1596. doi: 10.1111/all.13384. Epub 2018 Mar 12.

PMID:
29318628
34.

Phenotypic Spectrum of Children with Nephronophthisis and Related Ciliopathies.

König J, Kranz B, König S, Schlingmann KP, Titieni A, Tönshoff B, Habbig S, Pape L, Häffner K, Hansen M, Büscher A, Bald M, Billing H, Schild R, Walden U, Hampel T, Staude H, Riedl M, Gretz N, Lablans M, Bergmann C, Hildebrandt F, Omran H, Konrad M; Gesellschaft für Pädiatrische Nephrologie (GPN).

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1974-1983. doi: 10.2215/CJN.01280217. Epub 2017 Nov 16.

35.

Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism.

Kahaly GJ, Riedl M, König J, Diana T, Schomburg L.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4333-4341. doi: 10.1210/jc.2017-01736.

PMID:
29092078
36.

An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension.

Riedl MA, Bernstein JA, Craig T, Banerji A, Magerl M, Cicardi M, Longhurst HJ, Shennak MM, Yang WH, Schranz J, Baptista J, Busse PJ.

Clin Transl Allergy. 2017 Oct 6;7:36. doi: 10.1186/s13601-017-0172-9. eCollection 2017.

37.

Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation.

Boland BS, Riedl MA, Valasek MA, Crowe SE, Sandborn WJ.

Am J Gastroenterol. 2017 Oct;112(10):1621. doi: 10.1038/ajg.2017.246. No abstract available.

38.

Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.

Riedl MA, Li HH, Cicardi M, Harper JR, Relan A.

Allergy Asthma Proc. 2017 Nov 13;38(6):462-466. doi: 10.2500/aap.2017.38.4090. Epub 2017 Sep 13.

PMID:
28903805
39.

Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice.

Peterson CD, Kitto KF, Akgün E, Lunzer MM, Riedl MS, Vulchanova L, Wilcox GL, Portoghese PS, Fairbanks CA.

Pain. 2017 Dec;158(12):2431-2441. doi: 10.1097/j.pain.0000000000001050.

40.

Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.

Doolen S, Cook J, Riedl M, Kitto K, Kohsaka S, Honda CN, Fairbanks CA, Taylor BK, Vulchanova L.

Glia. 2017 Dec;65(12):1976-1989. doi: 10.1002/glia.23208. Epub 2017 Aug 29.

41.

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.

Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M.

Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25.

PMID:
28754491
42.

Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.

Kern W, Holstein A, Moenninghoff C, Kienhöfer J, Riedl M, Kulzer B.

Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):592-597. doi: 10.1055/s-0043-112350. Epub 2017 Jul 27.

43.

The role of von Willebrand factor in thrombotic microangiopathy.

Noone DG, Riedl M, Licht C.

Pediatr Nephrol. 2018 Aug;33(8):1297-1307. doi: 10.1007/s00467-017-3744-y. Epub 2017 Jul 26. Review.

PMID:
28748411
44.

Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation.

Geng B, Eastman JJ, Mori K, Braskett M, Riedl MA.

Ann Allergy Asthma Immunol. 2017 Sep;119(3):258-261. doi: 10.1016/j.anai.2017.06.009. Epub 2017 Jul 23.

PMID:
28743423
45.

Angioedema: Challenges and Insights.

Riedl MA.

Immunol Allergy Clin North Am. 2017 Aug;37(3):xv-xvi. doi: 10.1016/j.iac.2017.05.001. No abstract available.

PMID:
28687115
46.

Emerging Therapies in Hereditary Angioedema.

Chen M, Riedl MA.

Immunol Allergy Clin North Am. 2017 Aug;37(3):585-595. doi: 10.1016/j.iac.2017.03.003. Review. Erratum in: Immunol Allergy Clin North Am. 2017 Nov;37(4):xiii.

47.

Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States.

Riedl MA, Banerji A, Busse PJ, Johnston DT, Davis-Lorton MA, Patel S, Parr H, Chiao J, Watson DJ, Burrell E, Machnig T.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):59-64. doi: 10.1016/j.anai.2017.05.017.

PMID:
28668241
48.

Therapeutic plasma exchange in children: One center's experience.

Cortina G, Ojinaga V, Giner T, Riedl M, Waldegger S, Rosales A, Trojer R, Hofer J.

J Clin Apher. 2017 Dec;32(6):494-500. doi: 10.1002/jca.21547. Epub 2017 May 9.

PMID:
28485072
49.

Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.

Belur LR, Temme A, Podetz-Pedersen KM, Riedl M, Vulchanova L, Robinson N, Hanson LR, Kozarsky KF, Orchard PJ, Frey WH 2nd, Low WC, McIvor RS.

Hum Gene Ther. 2017 Jul;28(7):576-587. doi: 10.1089/hum.2017.187. Epub 2017 Apr 20.

50.

Torsional stiffness after subtalar arthrodesis using second generation headless compression screws: Biomechanical comparison of 2-screw and 3-screw fixation.

Riedl M, Glisson RR, Matsumoto T, Hofstaetter SG, Easley ME.

Clin Biomech (Bristol, Avon). 2017 Jun;45:32-37. doi: 10.1016/j.clinbiomech.2017.04.004. Epub 2017 Apr 19.

PMID:
28458187

Supplemental Content

Support Center